MCM2: An alternative to Ki-67 for measuring breast cancer cell proliferation

This publication has 72 references indexed in Scilit:

• BreastMark: An Integrated Approach to Mining Publicly Available Transcriptomic Datasets Relating to Breast Cancer Outcome
  Breast Cancer Research, 2013
• Prediction of the Oncotype DX recurrence score: use of pathology-generated equations derived by linear regression analysis
  Laboratory Investigation, 2013
• Molecular subclasses of breast cancer: how do we define them? The IMPAKT 2012 Working Group Statement
  Annals of Oncology, 2012
• Comprehensive molecular portraits of human breast tumours
  Nature, 2012
• The current state of breast cancer classification
  Annals of Oncology, 2012
• Aurora kinase A outperforms Ki67 as a prognostic marker in ER-positive breast cancer
  British Journal of Cancer, 2012
• Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study
  The Lancet Oncology, 2011
• Gene signatures in hepatocellular carcinoma (HCC)
  Seminars in Cancer Biology, 2010
• Ki67 in breast cancer: prognostic and predictive potential
  The Lancet Oncology, 2010
• Common markers of proliferation
  Nature Reviews Cancer, 2006